OminiWell Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
OminiWell General Information
Description
Developer of in vitro three-dimensional cell culture technology designed for advanced drug interaction testing. The company's platform utilizes specialized 3D cell models to accurately simulate human organ and tissue responses, facilitating the personalized assessment of new drug compounds and complex treatment interactions for cancer and other critical diseases, enabling pharmaceutical developers and medical professionals to reduce reliance on animal testing, accelerate the validation of novel therapies, and deliver personalized medicines tailored to individual patient needs.
Contact Information
Website
www.ominiwell.comCorporate Office
- Enterprise Hub, 9 Light Square
- Adelaide, South Australia 5000
- Australia
Corporate Office
- Enterprise Hub, 9 Light Square
- Adelaide, South Australia 5000
- Australia
OminiWell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 02-Jul-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 30-Apr-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 30-Jun-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 26-Jun-2020 | Completed | Generating Revenue |
OminiWell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
OminiWell Patents
OminiWell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019903669-A0 | Organotypic culture platform and uses thereof | Inactive | 30-Sep-2019 | ||
| AU-2020358122-A1 | Three-dimensional cell culture platform and uses thereof | Active | 30-Sep-2019 | ||
| AU-2020358122-A2 | Three-dimensional cell culture platform and uses thereof | Active | 30-Sep-2019 | ||
| AU-2020358122-B2 | Three-dimensional cell culture platform and uses thereof | Active | 30-Sep-2019 | ||
| US-12454668-B2 | Three-dimensional cell culture platform and uses thereof | Active | 30-Sep-2019 | C12M25/04 |
OminiWell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
OminiWell Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cicada Innovations | Accelerator/Incubator | |||
| Medtech Actuator | Accelerator/Incubator | Minority | ||
| CSIRO | Accelerator/Incubator | |||
| Innovation and Collaboration Centre | Accelerator/Incubator |
OminiWell FAQs
-
When was OminiWell founded?
OminiWell was founded in 2020.
-
Where is OminiWell headquartered?
OminiWell is headquartered in Adelaide, Australia.
-
What is the size of OminiWell?
OminiWell has 5 total employees.
-
What industry is OminiWell in?
OminiWell’s primary industry is Drug Discovery.
-
Is OminiWell a private or public company?
OminiWell is a Private company.
-
What is OminiWell’s current revenue?
The current revenue for OminiWell is .
-
How much funding has OminiWell raised over time?
OminiWell has raised $736K.
-
Who are OminiWell’s investors?
Cicada Innovations, Medtech Actuator, CSIRO, and Innovation and Collaboration Centre have invested in OminiWell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
